Eli Lilly & Co. (LLY)

1174.61 -1.49 (-0.13%) USD  |  NYSE  |  Aug 28, 16:00
1172.99 -1.62 (-0.14%) After-Hours: 20:00
More

Eli Lilly Cash and Short Term Investments (Quarterly) : 8.95B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 8.95B
March 31, 2026 5.282B
December 31, 2025 7.268B
September 30, 2025 9.914B
June 30, 2025 3.546B
March 31, 2025 3.221B
December 31, 2024 3.423B
September 30, 2024 3.518B
June 30, 2024 3.364B
March 31, 2024 2.586B
December 31, 2023 2.928B
September 30, 2023 2.494B
June 30, 2023 2.829B
March 31, 2023 3.669B
December 31, 2022 2.212B
September 30, 2022 2.742B
June 30, 2022 2.737B
March 31, 2022 2.568B
December 31, 2021 3.909B
September 30, 2021 3.825B
June 30, 2021 3.271B
March 31, 2021 3.051B
December 31, 2020 3.681B
September 30, 2020 3.630B
June 30, 2020 2.388B
Date Value
March 31, 2020 1.777B
December 31, 2019 2.438B
September 30, 2019 1.653B
June 30, 2019 2.368B
March 31, 2019 2.137B
December 31, 2018 7.409B
September 30, 2018 9.036B
June 30, 2018 6.910B
March 31, 2018 4.790B
December 31, 2017 8.034B
September 30, 2017 6.943B
June 30, 2017 5.434B
March 31, 2017 3.506B
December 31, 2016 6.039B
September 30, 2016 4.227B
June 30, 2016 3.935B
March 31, 2016 2.995B
December 31, 2015 4.452B
September 30, 2015 4.319B
June 30, 2015 4.231B
March 31, 2015 4.140B
December 31, 2014 4.827B
September 30, 2014 4.810B
June 30, 2014 5.126B
March 31, 2014 5.212B

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Johnson & Johnson 20.76B
Merck & Co., Inc. 7.182B
Pfizer Inc. 11.70B
Bristol Myers Squibb Co. 11.07B
Atai Beckley, Inc. 225.81M